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Summary
 
During immune responses the initial activation of B cells takes place in T cell zones of periarte-
riolar lymphoid sheaths (PALS) of the splenic white pulp. After initial activation, B cells mi-
grate into the primary follicles and, in association with follicular dendritic cells (FDCs), un-
dergo clonal expansion and differentiation giving rise to germinal centers (GCs). Peanut
agglutinin binding (PNA
 
1
 
) cells of the GC differentiate further into memory or plasma cells.
Here we report that in tumor necrosis factor receptor 1–deficient mice (TNFR1
 
2
 
/
 
2
 
), the loca-
tion of B cells was altered and that plasma cells were abnormally distributed in the splenic
PALS. In contrast to lymphotoxin 
 
a
 
–deficient mice (LT
 
a
 
2
 
/
 
2
 
), bone marrow or fetal liver
transplantation did not correct the abnormal organization of the spleen, location of B cells, the
lack of an FDC network, nor the antibody response in TNFR1
 
2
 
/
 
2
 
 mice. These results argue
for a crucial role of TNFR1 expression on nonhematopoietic cells for the maintenance of the
splenic architecture and proper B cell location. In addition, the lack in development of an FDC
network after adoptive transfer suggests that either FDCs are not of bone marrow origin or that
they depend on signals from nonhematopoietic cells for maturation.
 
T
 
he immune system often requires the cognate interac-
tions of T cells, B cells, and antigen-presenting cells to
respond to invading antigens/pathogens (1). A primary B cell
follicle contains surface (s)IgM
 
1
 
IgD
 
1
 
 resting recirculating
B cells and follicular dendritic cells (FDCs)
 
1
 
. A secondary B
cell follicle is composed of a follicular mantle containing
sIgM
 
1
 
IgD
 
1
 
 resting B cells and a germinal center (GC)
composed of centroblasts, centrocytes, activated CD4
 
1
 
memory T cells, and FDCs (2, 3). In addition, a third com-
partment, the marginal zone, observed in spleen, contains a
subset of nonrecirculating sIgM
 
high
 
IgD
 
low
 
 B cells (4, 5), mar-
ginal zone macrophages, as well as marginal metallophilic
macrophages  (6–8).
GCs are sites of B cell activation in secondary lymphoid
tissues (9) and FDCs represent the major nonlymphoid cellular
component of a GC, retaining the antigen as an immune
complex and providing a variety of costimulatory signals.
Within the GC, the B cells closely interact with FDCs and
T cells, providing both stimuli to the B cells that prevent
their entry into apoptosis and promote their differentiation
into memory cells or plasma cells (10). FDCs are thought to
be required to support formation and maturation of GCs (3,
11, 12). In support of this concept, both FDC clusters and
GCs are absent from the spleens of immunized lympho-
toxin 
 
a
 
–deficient (LT-
 
a
 
2
 
/
 
2
 
), TNF-
 
a
 
2
 
/
 
2
 
, and TNFR1
 
2
 
/
 
2
 
mice (13–15).
TNF-
 
a
 
 and LT-
 
a
 
 bind to the same receptors: TNFR1
(P55/CD120a) and TNFR2 (P75/CD120b) (16). In addi-
tion, when a LT-
 
a
 
 monomer trimerizes with two identical
LT-
 
b
 
 subunits, the heterotrimers bind to a third type of re-
ceptor, LT-
 
b
 
R (17). Mice with targeted disruption of the
LT-
 
a
 
 gene manifest congenital absence of LNs and Peyer’s
patches (18, 19). The splenic white pulp is reduced and
lacks clearly defined B and T cell compartments. Mice defi-
cient for another TNFR1 ligand, TNF-
 
a
 
, also lack GCs
and FDCs (15). TNFR1
 
2
 
/
 
2
 
 mice retain a normal layer of
 
1
 
Abbreviations used in this paper:
 
 BM, bone marrow; FDC, follicular dendritic
cell; FL, fetal liver; GC, germinal center; LT-
 
a
 
, lymphotoxin 
 
a
 
–deficient;
PALS, periarteriolar lymphoid sheaths; PNA, peanut agglutinin; RT,
room temperature; s, surface; SRBC, sheep red blood cell; WT, wild type.
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marginal metallophilic macrophages, yet they cannot form
an organized FDC network and GCs (14). Since no such
defect can be observed in TNFR2
 
2
 
/
 
2
 
 mice (13, 20), the
activity to form GC and FDC networks in response to
TNF-
 
a
 
 homotrimers is most probably signaled exclusively
through the TNFR1.
Distinct signals regulate the formation of discrete B and
T cell zones in the splenic white pulp and LNs (21). T and
B cell segregation in the splenic white pulp requires expres-
sion of LT-
 
a
 
 and is independent of TNFR1 (21). Further-
more, activation of B cells to form GC-like structures of
peanut agglutinin (PNA)-binding cells can occur in the
mesenteric LNs of LT-
 
a
 
2
 
/
 
2
 
 and TNFR1
 
2
 
/
 
2
 
 mice, but not
in their spleens (21). But, strikingly, both LT-
 
a
 
2
 
/
 
2
 
 and
TNFR1
 
2
 
/
 
2
 
 mice lack FDCs in both LNs and spleen (21).
Here we report that a significant number of plasma cells
were abnormally located in the periarteriolar lymphoid
sheaths (PALS) of the TNFR1
 
2
 
/
 
2
 
 mice. Neither wild-type
bone marrow (WT-BM) nor wild-type fetal liver (WT-FL)
transplantation could normalize the distribution pattern of
plasma cells in TNFR1
 
2
 
/
 
2
 
 spleen. In contrast to LT-
 
a
 
2
 
/
 
2
 
mice, the spleen architecture of TNFR1
 
2
 
/
 
2
 
 mice, includ-
ing GC and FDC networks, also could not be rescued by
transplantation of wild-type hematopoietic precursors. Taken
together, our findings illustrate that TNFR1 expressed by
nonhematopoietic elements is essential for proper distribu-
tion of B cells, de novo plasma cells, and formation of FDC
networks.
 
Materials and Methods
 
Mice.
 
C57BL/6 (Ly 5.1 and Ly 5.2 strains) and hybrid 129 Sv 
 
3
 
C57BL/6 mice were bred and maintained under specific patho-
gen-free conditions in the animal facility of the Basel Institute for
Immunology (Basel, Switzerland) or in conventional animal facil-
ities of the Cantonal Hospital Research Department and the
Swiss Tropical Institute (Basel, Switzerland). LT-
 
a
 
2
 
/
 
2
 
 mice (19)
and TNFR1
 
2
 
/
 
2
 
 mice (14) were maintained in Ly 5.1 genetic
background. Fetal liver cells were obtained from 14-d pregnant
mice. The day of the vaginal plug was counted as day 1 of preg-
nancy.
 
Reagents.
 
Primary antibodies for FACScan
 
Ò
 
 (Becton Dickin-
son, San Jose, CA), immunofluorescence, and immunohisto-
chemical analysis included rat anti–mouse CD19, biotin-conju-
gated mouse anti–mouse Ly 5.1 (clone 104-2), and Ly 5.2 (clone
A-20; these antibodies were a gift from A. Rolink, Basel Institute
for Immunology, Basel, Switzerland), FITC-labeled mouse anti–
mouse Ly 5.1 and Ly 5.2 (both provided by S. Takeda, Kyoto
University, Kyoto, Japan), rat anti–mouse Syndecan-1 (clone
281-2; references 22–29), PE-labeled rat anti–mouse B220 (clone
RA3-6B2), FITC-labeled hamster anti–mouse CD3-
 
e
 
 (clone 145-
2C11)  FITC– or Texas red–conjugated rat anti–mouse IgM
(clone R6-60.2) (these antibodies from PharMingen, Hamburg,
Germany), rat anti–mouse FDC-M2 (clone 209; reference 30),
and rat anti–mouse Thy-1 (clone T24).
Secondary antibodies and reagents included streptavidin-
PerCP–, -FITC–, or -Texas red–conjugated mouse anti–rat IgG
(Becton Dickinson), FITC–conjugated and biotin-conjugated
mouse anti–rat IgG (both from Jackson ImmunoResearch Labo-
ratories, West Grove, PA) antibodies, and biotinylated PNA (Vec-
 
tor Labs., Burlingame, CA). Immunohistochemistry was devel-
oped with ABC kit followed by incubation with 0.5 mg/ml
solution of diaminobenzidine substrate (both from Vector Labs.).
 
Bone Marrow and Fetal Liver Transplantation.
 
BM was harvested
and recipients were prepared as previously described (31). Recip-
ient mice received a lethal total-body irradiation (900 rad) before
the intravenous injection of 2–9 
 
3
 
 10
 
6
 
 freshly collected bone
marrow cells from Ly 5.2-C57BL/6 mice or 8 
 
3
 
 10
 
6
 
 fetal liver
cells from 14-d-old Ly 5.2-C57BL/6 embryos.
 
FACScan
 
Ò
 
 Analysis.
 
The pattern of donor- versus recipient-
derived cells was analyzed by a double labeling technique. To
block Fc receptor–mediated binding of antibodies, cells were pre-
incubated for 15 min at 4
 
8
 
C with mouse IgG (Sigma Chemical
Co., Bucks, Switzerland) in PBS containing 1% BSA and 0.1%
sodium azide. Afterwards, cells were incubated for 20 min at 4
 
8
 
C
with the following primary antibodies: anti-Ly 5.1-biotin, anti-
Ly 5.1-FITC, anti-Ly 5.2-biotin, anti-Ly 5.2-FITC, anti-CD3-
 
e
 
-FITC, or B220-PE, washed, and sequentially incubated, when
necessary, with streptavidin-PerCP for 20 min at 4
 
8
 
C. FITC and
PerCP fluorescence of the cells was measured with a FACScan
 
Ò
 
(Becton Dickinson) using excitation light from an argon laser at
488 nm. Electronic gates were set so that 
 
z
 
85% of the observed
cells belonged to the lymphocyte population. Samples were ana-
lyzed by comparison with negative and positive controls to deter-
mine the cut off for positively labeled cells.
 
Immunization.
 
8–12-wk-old mice of each strain were in-
jected intraperitoneally at day 0 with either 2 
 
3
 
 10
 
8
 
 sterile sheep
red blood cells (SRBC), 100 
 
m
 
g of ovalbumin (Miles Inc., Elkhart,
IN), or with 100 
 
m
 
g of KLH (Chemicon International Inc., Te-
mecula, CA). The protein antigens were mixed with incomplete
Freund’s adjuvant (Difco Laboratories, Detroit, MI). KLH ad-
ministration was repeated 12 d after the priming. 16 d after im-
munization with ovalbumin, spleens were obtained for histologi-
cal processing. The spleens from KLH immune mice were
obtained 30 d after the priming.
 
Immunohistological Analysis of Spleen Sections.
 
Spleens were em-
bedded in Tissue-Tec (Miles Inc.) and frozen on dry ice. 7-
 
m
 
m-thick
cryosections were fixed in acetone for 10 min and incubated with
the primary antibody for 30 min at room temperature (RT). Im-
munofluorescent labeling was performed with fluorescein or Texas
red secondary antibodies by incubation for 30 min at RT. The
immunohistochemical procedure was followed by incubation
with biotin-conjugated secondary antibodies for 30 min at RT, and
revealed with ABC kit and diaminobenzidine substrate (as described
in manufacturer’s protocol, Vector Labs.). All incubations were
terminated by washing with PBS. To demonstrate the histology of
the spleen, the sections were counterstained with 0.5% solution
of methyl green zinc chloride (Merck, Darnstadt, Germany).
 
Assay of Immunoglobulins.
 
Specific anti-SRBC IgM and IgG1
antibodies in serum were quantitated using a sandwich ELISA as
described previously (14, 21). In brief, maxisorp microtiter plates
(Nunc, Roskilde, Denmark) were coated overnight with 50 
 
m
 
l of
a solubilized extract (3 mg/ml) from SRBCs. Thereafter, the
plates were blocked with 2% BSA in PBS for 2 h at 37
 
8
 
C. Serial
dilutions of the sera were added and incubation was performed
overnight at RT. Bound antibodies were detected by incubation
with biotinylated goat anti–mouse IgM- and IgG1-specific anti-
bodies (both from Southern Biotechnology, Birmingham, AL)
for 4 h at RT. Plates were developed by the addition of streptavi-
din-AP conjugate (Amersham, Buckinghamshire, UK) followed
by Sigma 104
 
Ò
 
 phosphatase substrate (Sigma Chemical Co.) for
45 min each. The reaction was stopped with 1.5 M NaOH. Ab-
sorbance was read at 405 nm. 
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Results
 
Reconstitution of the Hematopoietic System in TNFR1
 
2
 
/
 
2
 
and LT-
 
a
 
2
 
/
 
2
 
 Mice by Transplantation of Wild-type Hematopoi-
etic Precursor Cells.
 
In an attempt to restore the immune
system in LT-
 
a
 
2
 
/
 
2
 
 and TNFR1
 
2
 
/
 
2
 
 mice, deficient animals
were lethally irradiated (900 rad) and reconstituted with an
intravenous injection of 10
 
7
 
 FL cells or 2 
 
3 106 BM cells
from B6-Ly 5.2 congenic donors. 1 mo after FL or BM
transplantation, the majority of spleen cells and peripheral
blood lymphocytes from LT-a2/2 and TNFR12/2 recon-
stituted mice already were of donor origin (data not
shown). Antibodies against Ly 5.1 and Ly 5.2 allotypic
markers demonstrated that within a period of 2–10 mo af-
ter transplantation, the ratio between donor- and recipient-
derived lymphocytes remained stable in spleen as well as in
peripheral blood (data not shown). The majority of lym-
phocytes in both spleen (Table 1) and peripheral blood
(data not shown) of reconstituted animals expressed the Ly
5.2 surface marker and therefore were of donor origin.
More than 95% of T and B cells had been derived from do-
nor type precursors. Moreover, immunohistochemical la-
beling of spleen cryosections also revealed the dominant
presence of Ly 5.2-positive donor-derived cells (data not
shown). Taken together, these data show that transplanta-
tion of bone marrow or fetal liver cells efficiently repopu-
lated the lymphocyte compartment of TNFR1 or LT-a2/2
mice with wild-type hematopoietic cells.
In Contrast to LT-a2/2 mice, B Cell Follicles and GCs Can-
not Be Restored by BM or FL Transplantation in TNFR12/2
Mice. Using immunohistochemical (Fig. 1) and immu-
nofluorescence (Fig. 2) methods, the splenic architecture in
TNFR12/2 and LT-a2/2 mice after WT-BM adoptive
transfer was compared. As shown in these figures, WT-BM
transplantation was sufficient to reconstitute most features
of the splenic architecture in LT-a2/2 mice, as was previ-
ously shown (31). Indeed, discrete B cell follicles, absent in
LT-a2/2 spleen (Figs. 1 m, and 2 m and o) appeared after
BM transplantation (Figs. 1 q, and 2 q and r). WT-BM re-
constitution rescued also the development of GC (PNA1
clusters; Fig. 2 r), absent in LT-a2/2 mice (Fig. 2 n). This
phenotype developed as soon as 1 mo after the transplanta-
tion and was stable for at least 10 mo.
In contrast to reconstituted LT-a2/2 mice, these ele-
ments in TNFR12/2 mice (Figs. 1 e, and 2 e and g) were
not restored after WT-BM cell transfer (Figs. 1 i, and 2, i
and j). Even after immunization with ovalbumin, the GCs,
which appeared in the spleen of wild-type mice (Fig. 2 b),
were absent in the spleen of both TNFR12/2 (Fig. 2 f) and
TNFR12/2 reconstituted (Fig. 2 j) mice. Similar results
were obtained after immunization with KLH (data not
shown). Transplantation of WT-FL cells also failed to res-
cue the splenic architecture in TNFR12/2 mice examined
for over a 10-mo period (data not shown). Our data sug-
gest that the expression of TNFR1 on nonhematopoietic
cells is a prerequisite for the development of B cell follicles
and GC in murine spleens.
In Contrast to LT-a2/2 Mice, WT- BM or WT-FL Trans-
plantation Cannot Repopulate FDC Networks in TNFR12/2
Mice. Experiments were also performed to determine
whether FDC networks, a major functional component of
GCs, were restored in the spleen after transfer experiments.
Labeling performed with the rat anti–mouse FDC-M2 an-
tibody demonstrated that FDC networks can be rescued by
WT-BM transplantation in LT-a2/2 mice (arrows, Fig. 2 r),
but not in TNFR12/2 mice (Fig. 2 j). No FDC networks
were detected in TNFR12/2 reconstituted mice upon im-
munization with ovalbumin (Fig. 2), KLH, or SRBC (data
not shown). Even 10 mo after BM transplantation, no
FDC-M2 reactivity was observed in the reconstituted
TNFR12/2 spleens (data not shown). This defect was also
not corrected by WT-FL transplantation (data not shown).
Therefore, neither WT-BM nor WT-FL transplantation
were sufficient to restore FDC networks in TNFR12/2
mice.
Abnormal Distribution of Plasma Cells in TNFR12/2 Mice
Cannot Be Corrected by WT-BM or WT-FL Transplanta-
tion. A striking observation of the TNFR12/2 mice was a
localization of plasma cells within the T cell area of the
white pulp (Figs. 1 and 2 g). In contrast, this type of distri-
bution of antibody-secreting cells was not observed in the
spleen of WT, LT-a2/2, or LT-a2/2 reconstituted mice.
In WT mice, after ovalbumin immunization, plasma cells
tended to accumulate in the peripheral area of the PALS, in
the marginal zone, and in the red pulp (brown-stained cells,
Fig. 1 c; bright red–stained cells, Fig. 2 c). As distinct T and B
lymphocyte compartments did not form in the spleen of
LT-a2/2 mice (21), it was difficult to draw conclusions
about the distribution of their plasma cells. However, they
Table 1. FACScanÒ Analysis of Host- Versus Donor–derived 
Hematopoietic Cells in the Spleen of LTa and TNFR1–deficient Mice 
Reconstituted with WT-FL or WT-BM*
Cell surface
markers
Percentage of marker-positive cells
in splenocyte population
TNFR12/2
WT-FL rec
(n 5 5)‡
TNFR12/2
WT-BM rec
(n 5 3)
LT-a2/2
WT-BM rec
(n 5 2)
Ly 5.11 12 6 29  6  21 0
Ly 5.21 85 6 2 89 6 18 2
B2201/Ly 5.11 0 6 10  6  1N D
B2201/Ly 5.21 69 6 2 67 6 27 2
CD3e1/Ly 5.11 0 6 20  6  1N D
CD3e1/Ly 5.21 13 6 2 13 6 11 1
* Total fetal liver cells or bone marrow cells (C57B1/6, Ly 5.2) were in-
jected intravenously into lethally irradiated TNFR1–and LT-a–defi-
cient mice (129 3 C57BL/6, Ly 5.1). 2 mo after transplantation, sple-
nocytes were analyzed by flow cytometry for the presence of host (Ly
5.1)–versus donor (Ly 5.2)–derived lymphocytes. Data are presented as
percentage of cells positive for the surface markers within the popula-
tion of 104 splenocytes: mean % 6 SD.
‡Number of animals analyzed per group.472 Nonhematopoietic TNFR1 Expression and B Cell Location
appeared to be clustered in an area similar to red pulp (Figs.
1 and 2 o). In the spleen of LT-a2/2 mice reconstituted
with WT-BM, the plasma cells were located in the red
pulp and periphery of the T cell zone (Fig. 1 s, and 2 q and s).
In both, TNFR12/2 (Fig. 2 g) and TNFR12/2 reconsti-
tuted mice (Fig. 2 k), the IgM1 plasma cells were distrib-
uted mainly in the PALS. Similar results were obtained
from TNFR12/2 mice reconstituted with WT-BM or
WT-FL and immunized with KLH or ovalbumin. Further-
more, labeling with Syndecan-1, a specific marker of
plasma cells (22–29), confirmed the localization of plasma
cells in the outer periphery of the T cell areas in both WT
(brown-stained cells, Fig. 1 c) and LT-a2/2 reconstituted mice
(Fig. 1 s), and inside the PALS in both TNFR12/2 (Fig. 1
g, and arrowheads, Fig. 2 g) and reconstituted TNFR12/2
mice (Fig. 1 k, and arrowheads, Fig. 2 k). In addition to
these atypically located plasma cells, few plasma cells were
also present in the red pulp of TNFR12/2 (Figs. 1 and 2 g)
and reconstituted TNFR12/2 mice (Figs. 1 and 2 k).
To better demonstrate the morphology of plasma cells, a
Figure 1. Reconstitution of TNFR1-deficient mice with WT-BM fails to restore B cell follicles and normalize the distribution of plasma cells. Spleens
from immune WT (a–d), TNFR1-deficient (R12/2; e–h), TNFR1-deficient WT-BM–reconstituted (R1rec; i–l), LT-a–deficient (LT2/2; m–p) and LT-
a–deficient WT-BM reconstituted (LTrec; q–t) mice were labeled by immunoperoxidase (brown) for B cells with an anti-CD19 mAb, T cells with an anti-
Thy-1 mAb, and plasma cells with the Syndecan 1 mAb. Note the lack of primary follicles in the sections of TNFR1-deficient (R12/2; e), TNFR1-defi-
cient WT-BM reconstituted (R1rec; i), and LT-a–deficient (LT2/2; m) mice. When comparing adjacent sections of Thy 1 and Syndecan-1 labeling,
plasma cells are abnormally observed in the Thy 1–positive areas of TNFR1-deficient (R12/2; f and g) and WT-BM–reconstituted (R1rec; j and k) mice.
Higher magnifications of the areas outlined in g, k, o, and s are shown in h, l, p, and t, respectively, whereas d is a higher magnification of an area in the
red pulp not seen in c. The sections shown are from two months after transplantation. Arrows, central arterioles.473 Tkachuk et al.
higher magnification of the areas containing these cells are
presented (Figs. 1 and 2, d, h, l, p, and t). Syndecan-11 cells
(Fig. 1, d, h, l, p, and t) and IgM1 plasma cells (Fig. 2, d, h, l,
p, and t) showed similar morphology in both the red pulp
and PALS in all groups of mice. Together, these data suggest
that in the absence of TNFR1 expression by nonhemato-
poietic cells, plasma cells are located mainly in the PALS. 
Failure to Induce a Significant IgG1 Response in TNFR12/2
Mice Reconstituted in WT-BM Cells. The functional poten-
tial of WT hematopoietic cells differentiated in the lymphoid
microenviroment of LT-a2/2 and TNFR12/2 reconsti-
tuted mice was monitored by their ability to respond to T
cell–dependent antigens. The titers of antigen-specific IgM
and IgG1 antibodies were measured by ELISA after immu-
nization with SRBCs. The level of the IgM response was
similar in all animals examined (Fig. 3, A and C). In con-
trast, the IgG1 response that was deficient in both TNFR12/2
(14, 33) and LT-a2/2 mice was restored in LT-a2/2 mice
(Fig. 3 B; reference 31) but not in TNFR12/2 mice (Fig. 3
D) after WT-BM transplantation. These data demonstrate a
Figure 2. Reconstitution of TNFR1-deficient mice with WT-BM cells fails to restore GCs, FDC networks, and the distribution of plasma cells.
Spleens from immune wild-type (WT; a–d), TNFR1-deficient (R12/2; e–h), TNFR1-deficient WT-BM–reconstituted (R1rec; i–l), LT-a–deficient
(LT2/2; m–p), and LT-a–deficient WT-BM–reconstituted (LTrec; q–t) mice were double labeled by immunofluorescence for B (red) and plasma cells
(bright red) with an anti-IgM antibody coupled to Texas red (a, c–e, g–i, k–m, o–q, s, and t); GC B cells by FITC (green; a, e, i, m, and q), or Texas red (red;
b, f, j, n, and r)–coupled PNA; FDC networks with the FDC-M2 mAb (green; b, f, j, n, and r), and T cells with an anti-Thy 1 mAb (green; c, g, k, o, and s).
Note the presence of PNA1 GCs only in a, b, q, r, and FDC networks only in b and r (arrows). Also note the abnormal plasma cell distribution in g and k
(arrowheads) in the PALS (green). d, h, l, p, and t, are higher magnifications of the plasma cells observed in panels c, g, k, o, and s, respectively. The sections
shown are from 2 mo after transplantation.474 Nonhematopoietic TNFR1 Expression and B Cell Location
correlation between the disturbed splenic architecture and
incomplete antibody production in mice deficient for
TNFR1 expression on nonhematopoietic cells.
Discussion
Organized lymphoid tissues provide a critical framework
for many aspects of immune responses, but the nature of
cellular and molecular interactions responsible for the main-
tenance of peripheral lymphoid architecture is still poorly
understood. It has been demonstrated previously that
TNFR12/2 mice are deficient in GC formation (13), as
well as development of FDC networks and IgG responses
after SRBC immunization (14). The reconstitution of
TNFR12/2 mice with WT-BM or WT-FL provided a
model to study the function of wild-type hematopoietic
cells transferred into a TNFR1-deficient environment.
Here we report that the hematopoietic cell transfer was not
sufficient to restore the splenic architecture in TNFR12/2
mice. Secondary follicles, normally containing FDC net-
works, remained absent in the TNFR12/2 spleen after
WT-BM or WT-FL transplantation and immunization.
On the functional level, the TNFR12/2 reconstituted mice
were still deficient in the production of IgG1 after SRBC
immunization. As a control for the efficiency of the trans-
plantation procedure, we demonstrated restored GC for-
mation, rescued FDC networks, and normalized IgG1 pro-
duction in LT-a2/2 mice upon WT-BM transplantation
and SRBC immunization, which is in agreement with pre-
vious reports (13, 31, 34). We suggest that the expression
of TNFR1 on nonhematopoietic cells is an essential re-
quirement for development of correct splenic architecture
and full antibody responses.
The fact that FDC networks appeared after hematopoie-
tic cell transfer in LT-a2/2, but not in TNFR12/2 spleen,
makes the LT-a/TNFR12/2 model suitable to question
the origin of FDCs. There are controversial opinions in the
literature about the ability to transfer FDC precursors by
WT or FL transplantation. FDCs live long, seldom divide,
and change their morphology and phenotype during hu-
moral immune responses (35, 36). One FDC derivation
theory holds that FDCs are of local origin, probably devel-
oping from fibroblastic or primitive reticular cells (37–42)
or from mesenchymal cells (pericytes around capillaries;
reference 43). Another theory suggests BM and FL origin
of FDCs (36). The theory is based on the results of cell
transfer experiments from normal donors into lethally irra-
diated recipients (40) or recipients known to bear only
FDC precursors, but not fully differentiated FDC networks
(SCID mouse; references 44, 45). The nature of the exact
cell type in all of these theories has not been elucidated,
and such an indisputable determination of FDC origin re-
mains to be obtained.
The rescue of FDC networks in LT-a2/2 mice after
WT-BM transplantation argues for the presence of FDC
precursors either in WT-BM or in the LT-a2/2 mice
themselves. These results indicate that hematopoietic pre-
cursors that repopulate the LT-a–deficient mice provide
signals (probably the major signal is LT-a itself) for the
maturation of FDC precursor cells. Since the transplanta-
tion of WT-BM or WT-FL cells does not restore FDC
networks, it is not TNFR1 signaling of B cells that caused
the absence of FDC in the spleen of TNFR12/2 mice (46).
Instead, it appears that FDC precursors require the expres-
sion of TNFR1 for maturation. In addition, our data sug-
gest that FDC precursors either cannot be transferred by
BM/FL transplantation or they require the expression of
TNFR1 by stromal cells for homing. However, since rat
FDCs can develop in SCID mice after transfer of rat BM or
rat FL (45), we would favor the latter hypothesis.
We observed that the location of plasma cells within the
white pulp was generally disturbed in TNFR12/2 mice.
This defect could not be corrected by WT-BM or WT-FL
transplantation. However, the nature of these plasma cells
remains undefined (i.e., antigen specific versus natural im-
munity), but it appears that an abnormal distribution by at
least some differentiating B cells occurs in TNFR12/2 and
TNFR12/2 reconstituted spleens.
From these observations, we would like to propose the
following model of plasma cell induction in TNFR12/2
and TNFR12/2 reconstituted spleen. After a primary im-
munization, areas adjacent to the red pulp in the periphery
Figure 3. BM transplantation restores IgG1 responses in LT-a2/2, but
not in TNFR12/2 mice. Serum SRBC-specific immunoglobulin titers
were quantitated by the sandwich ELISA and expressed as the reciprocal
value of the dilution showing an optical density of 0.1 over background.
The mean value is indicated by a horizontal line. (A and B) IgM and IgG1
titers, respectively, monitored in LT-a2/2 (open boxes), LT-a2/2 recon-
stituted with WT-BM (gray boxes), and wild-type (black boxes) mice. The
difference between WT and LT-a2/2–reconstituted mice in IgG1 pro-
duction at day 14 was statistically insignificant (P .0.05); (C and D) IgM
and IgG1 titers, respectively, monitored in TNFR12/2 (open triangles),
TNFR12/2 reconstituted with WT-BM (gray triangles), and WT (black tri-
angles) mice. The difference between WT and TNFR12/2 -reconstituted
mice in IgG1 production at day 13 was statistically significant (P ,0.05).475 Tkachuk et al.
of PALS are known to develop foci of antigen-specific B
cells (30). These B cells differentiate to produce unmutated
IgM and IgG eventually undergoing apoptosis and disap-
pearing (30, 47–50). Data at present would suggest that the
primary activation of B cells in TNFR12/2 or TNFR12/2
reconstituted spleens is not altered. Later, in wild-type
mice, the second foci of B cell activation and differentia-
tion appear, within the B cell primary follicles (30). The
cells that seed GCs develop further and form dark zones
containing the majority of cells in cycle and the adjacent
light zones with an extensive FDC network. Although al-
ternative ideas have been proposed (51), a clonal relation-
ship exists between cells of these two compartments, i.e.,
the PALS and GCs (49). In TNFR12/2 or TNFR12/2 re-
constituted spleens some activated B cells differentiate into
plasma cells in the PALS without moving out into the tra-
ditional area. Since there are no characteristic FDC net-
works in PALS, we speculate that interdigitating dendritic
cells (IDCs) could be responsible for an antigen delivery to
the developing plasma cells. However, other cell types
present in PALS, such as stromal elements, may also partic-
ipate in this process.
In this report we demonstrate that the disrupted expres-
sion of TNFR1 on nonhematopoietic cells leads to an ab-
normal spleen architecture and antibody response. The
demonstration of an abnormal distribution of plasma cells
within the white pulp of TNFR12/2 mice is a first message
that signaling through this receptor may be important to
direct B cell traffic. The fact that this phenomenon is not
rescued even after wild-type hematopoietic cell transfer
strongly argues for the role of TNFR1 expression on non-
hematopoietic cells for the direction or promotion of B cell
location. Elucidating the role of nonhematopoietic cells in
obtaining compartmentalization of the spleen during im-
mune responses is yet another intriguing challenge.
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